Aptar Active Material Science first use of Activ-Film technology with a commercialized capsule-based Dry Powder Inhalation (DPI) drug product.
Aptar Active Material Science, part of AptarGroup, Inc. and a global leader in active material science solutions, announced its first use of Activ-Film technology with a commercialized capsule-based Dry Powder Inhalation (DPI) drug product.
The capsule-based DPI leverages Aptar’s Activ-Film technology to help safeguard the drug and support product performance throughout shelf life. This launch builds on past FDA approvals of oral solid dosage drugs, implants, and diagnostic products that incorporate this technology and marks Aptar’s first commercialization of Activ-Film™ technology for use with a dry powder inhalation system.
Activ-Film technology leverages the company’s 3-Phase Activ-Polymer platform, which provides a broad spectrum of customized and highly-engineered materials, deployed in a range of configurations. For this launch, Aptar’s Activ-Film material is integrated into the blister packaging that houses the DPI’s dry-powder capsules. In this configuration, a piece of custom-engineered Activ-Film material is sealed in an aluminum blister cavity with a channel connecting it to the drug product. This enables the properties of the Activ-Film material to control the microclimate inside the drug blister cavity without coming into contact with the drug capsule itself.
About Aptar Active Material Science
Aptar Active Material Science is part of AptarGroup, Inc., a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing. Aptar Active Material Science leverages its expertise to transform ideas into market opportunities, accelerate and de-risk the product development process, and provide complete solutions that improve consumers’ and patients’ lives.
For more information, visit www.csptechnologies.com and www.aptar.com.
Total Page Views: 2
